Formulation and Evaluation of Eudragit RL-100 Nanoparticles Loaded In-Situ Forming Gel for Intranasal Delivery of Rivastigmine

Purpose: Rivastigmine hydrogen tartrate (RHT) is commonly used for the treatment of mild to moderate Alzheimer’s disease (AD). The aim of this work was to formulate in-situ pluronic F-127 (PF-127) hydrogels containing Eudragit RL-100 (EU-RL) nanoparticles (NPs) in order to improve the therapeutic ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Salatin, Sara, Barar, Jaleh, Barzegar-Jalali, Mohammad, Adibkia, Khosro, Alami-Milani, Mitra, Jelvehgari, Mitra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tabriz University of Medical Sciences 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6983984/
https://www.ncbi.nlm.nih.gov/pubmed/32002358
http://dx.doi.org/10.15171/apb.2020.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6983984/
https://www.ncbi.nlm.nih.gov/pubmed/32002358
http://dx.doi.org/10.15171/apb.2020.003

Ejemplares similares